Legalize / European Union / Implementing Regulation

Commission Implementing Regulation (EU) 2024/860 of 18 March 2024 amending Regulation (EU) No 37/2010 as regards the substance 17β-oestradiol

Type Implementing Regulation

Publication 2024-03-19

State In force

Text As published

Department European Commission, SANTE

Source EUR-Lex

articles 2

This is the act as published. Later amendments are not folded into the text below: each one is a separate act in this repository and an entry in this law's history.

Reform history JSON API


Image omitted; see official source	Official Journal of the European Union	EN Series L

---	---	---
	2024/860	19.3.2024

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EC) No 470/2009 of the European Parliament and of the Council of 6 May 2009 laying down Community procedures for the establishment of residue limits of pharmacologically active substances in foodstuffs of animal origin, repealing Council Regulation (EEC) No 2377/90 and amending Directive 2001/82/EC of the European Parliament and of the Council and Regulation (EC) No 726/2004 of the European Parliament and of the Council ¹, and in particular Article 14 thereof,

Whereas:

(1) Commission Regulation (EU) No 37/2010 ² sets out the pharmacologically active substances and their classification regarding maximum residue limits (‘MRLs’) in foodstuffs of animal origin. It incorporated the pharmacologically active substances classified in the four Annexes to Council Regulation (EEC) No 2377/90 ³ which was repealed and replaced by Regulation (EC) No 470/2009.

(2) At the time of the adoption of Regulation (EU) No 37/2010, the substance 17β-oestradiol, which was included in Annex II (‘list of substances not subject to maximum residue limits’) to Regulation (EEC) No 2377/90, was included in Table 1 (‘allowed substances’) of the Annex to Regulation (EU) No 37/2010.

(3) Article 1(3) of Regulation (EC) No 470/2009 provides that Regulation (EC) No 470/2009 shall apply without prejudice to Community legislation prohibiting the use in food-producing animals of certain substances having a hormonal or thyrostatic action and of beta-agonists, as provided for by Council Directive 96/22/EC ⁴.

(4) Directive 96/22/EC prohibits the administering of 17β-oestradiol to farm animals.

(5) Therefore, it is appropriate to remove the substance 17β-oestradiol from Table 1 of Regulation (EU) No 37/2010.

(6) Regulation (EU) No 37/2010 should therefore be amended accordingly.

(7) The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products,

HAS ADOPTED THIS REGULATION:

Article 1

The Annex to Regulation (EU) No 37/2010 is amended as set out in the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 18 March 2024.

For the Commission

The President

Ursula VON DER LEYEN

OJ L 152, 16.6.2009, p. 11, ELI: http://data.europa.eu/eli/reg/2009/470/oj.

Commission Regulation (EU) No 37/2010 of 22 December 2009 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin (OJ L 15, 20.1.2010, p. 1, ELI: http://data.europa.eu/eli/reg/2010/37(1)/oj).

Council Regulation (EEC) No 2377/90 of 26 June 1990 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (OJ L 224, 18.8.1990, p. 1, ELI: http://data.europa.eu/eli/reg/1990/2377/oj);

Council Directive 96/22/EC of 29 April 1996 concerning the prohibition on the use in stockfarming of certain substances having a hormonal or thyrostatic action and of beta-agonists, and repealing Directives 81/602/EEC, 88/146/EEC and 88/299/EEC (OJ L 125, 23.5.1996, p. 3, ELI: http://data.europa.eu/eli/dir/1996/22/2008-12-18).

ANNEX

In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry for ‘17β-oestradiol’ is deleted.

ELI: http://data.europa.eu/eli/reg_impl/2024/860/oj

ISSN 1977-0677 (electronic edition)

Reading this document does not replace reading the official text published in the Official Journal of the European Union. We assume no responsibility for any inaccuracies arising from the conversion of the original to this format.

This text is published under EUR-Lex's own terms of reuse, not a Legalize or public-domain licence. EUR-Lex
Creative Commons Attribution 4.0 International (CC BY 4.0)
© European Union, https://eur-lex.europa.eu — Source: EUR-Lex (Publications Office of the European Union). Reused under the Creative Commons Attribution 4.0 International (CC BY 4.0) licence. Only EU legislation published in the printed Official Journal of the European Union is deemed authentic; consolidated texts are reproduced here for documentation purposes and have been reformatted to Markdown.